Bandingkan Harga & Kinerja Link Net Tbk. (LINK) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Link Net Tbk. dan Organon Pharma Indonesia Tbk.: Link Net Tbk. diperdagangkan di Rp1.780 (kapitalisasi pasar 4,77 T, volume 24 jam 125,9 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Link Net Tbk. jauh lebih besar — sekitar 45,7× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| LINK | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 4,77 T | 104,4 M |
Volume | 125,9 rb | — |
Lot | 1,26 rb | — |
Perputaran | 218,97 jt | — |
Harga Rata-rata | 1.739,27 | — |
Nilai Transaksi | 218,97 jt | — |
Harga Ekuilibrium Indikatif | 1.780 | — |
Volume Ekuilibrium Indikatif | 287 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Link Net Tbk.
PT Link Net Tbk (the Company) was established under the name of PT Seruling Indah Permai based in Nortarial Deed No. 93 dated 14 March 1996 of Dr. Misahardi Wilamarta, S.H., m.h., M.Kn, LL.M as amended by Notarial Deed No. 304 dated 26 July 1996 of Yuliandi Errmawanto, S.H. The parent of the Company is PT First Media Tbk, a company was incorporated in Indonesia and its shares have been listed on Indonesia Stock Exchange.
Selengkapnya di halaman LINK →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
